Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer

Posted on by

Nanoform Finland Plc April 9, 2024 09.00 EEST / 08.00 CEST HELSINKI, April 9, 2024 /PRNewswire/ — Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, today announced a collaboration with PlusVitech, a biotechnology company developing treatments for cancer, to…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.